InsidersTradesSigma
Discover the full record of transactions filed by Rovaldi Christopher, Dirigeant. Officer active across 1 companies, notably Keros Therapeutics, Inc.. Cumulatively, 2 filings have been published. The latest transaction was disclosed on 6 April 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Christopher Rovaldi is the Chief Operating Officer of Keros Therapeutics, Inc. In this role, he oversees the company's operations and ensures process efficiency. His expertise is essential for the smooth functioning of the organization.